TTOO

T2 Biosystems Inc

TTOO, USA

T2 Biosystems, Inc. engages in the development and commercialization of medical diagnostic products for critical unmet needs in the healthcare. Its products include T2Dx instrument, T2Candida panel, and T2Bacteria panel. The company was incorporated in 2006 and is based in Lexington, Massachusetts.

https://investors.t2biosystems.com

Stock Price

$ 0.00

0% decrease compared to yesterday.

Dividend

Frequency:

N/A

Rate:

N/A

Next Payout:

N/A
TTOO
stock
TTOO

T2 Biosystems (NASDAQ:TTOO) Shares Cross Above 50-Day Moving Average – What’s Next? Defense World

Read more →
TTOO
stock
TTOO

T2 Biosystems (NASDAQ:TTOO) Shares Cross Above 50 Day Moving Average – What’s Next? Defense World

Read more →

Showing 2 of 10

Analyst Ratings & Sentiment

(Last Updated 2024-09-30)

Rating:

HOLD

Target Price:

$5

Analyst Picks

Strong Buy

0

Buy

0

Hold

1

Sell

0

Strong Sell

0

Finn Analysis

(Last Updated 2024-09-30)

Health Score

Price to Book Ratio (P/B)

-

Very Low

-0.02

Low ≤ 1

High ≥ 3

Return on Equity (ROE)

-

Very High

86.40 %

Low ≤ 5%

High ≥ 25%

Return on Assets (ROA)

-

Very Low

-55.95 %

Low ≤ 2%

High ≥ 10%

Free Cash Flow - Revenue % (FCF)

-

Very Low

-314.96 %

Low ≤ 5%

High ≥ 15%

Investors

* Institutions hold a combined 9.21% of the total shares of T2 Biosystems Inc

1.

Armistice Capital, LLC

(4.9776%)

since

2024/09/30

2.

Vanguard Group Inc

(1.3919%)

since

2024/09/30

3.

Vanguard Total Stock Mkt Idx Inv

(0.552%)

since

2024/12/31

4.

Geode Capital Management, LLC

(0.324%)

since

2024/09/30

5.

BlackRock Inc

(0.2739%)

since

2024/09/30

6.

Spartan Total Market Index Pool E

(0.2353%)

since

2024/12/31

7.

State Street Corp

(0.2273%)

since

2024/09/30

8.

Susquehanna International Group, LLP

(0.1622%)

since

2024/09/30

9.

Extended Equity Market Fund K

(0.1445%)

since

2024/12/31

10.

Millennium Management LLC

(0.1396%)

since

2024/09/30

11.

Fidelity Extended Market Index

(0.1297%)

since

2024/12/31

12.

Northern Trust Corp

(0.0968%)

since

2024/09/30

13.

Fidelity Total Market Index

(0.0763%)

since

2024/12/31

14.

Kingswood Wealth Advisors LLC

(0.0713%)

since

2024/12/31

15.

NT Ext Equity Mkt Idx Fd - L

(0.0575%)

since

2024/12/31

16.

Northern Trust Extended Eq Market Idx

(0.0575%)

since

2024/12/31

17.

Goldman Sachs Group Inc

(0.0526%)

since

2024/09/30

18.

NT Ext Equity Mkt Idx Fd - NL

(0.0379%)

since

2024/12/31

19.

Fidelity Nasdaq Composite Index

(0.0329%)

since

2024/12/31

20.

Fidelity Series Total Market Index

(0.0312%)

since

2024/12/31

21.

NT Ext Equity Mkt Idx Fd - DC - NL - T2

(0.0301%)

since

2024/12/31

22.

Extended Equity Market Fund M

(0.0188%)

since

2024/12/31

23.

State St US Extended Mkt Indx NL Cl C

(0.0161%)

since

2025/01/31

24.

Royal Bank of Canada

(0.0143%)

since

2024/09/30

25.

NT Ext Eq Mkt Indx Fd DC Lend T3

(0.0137%)

since

2024/12/31

26.

NT Ext Eq Mkt Indx Fd DC Lend T4

(0.0137%)

since

2024/12/31

27.

NT Ext Eq Mkt Indx Fd DC Lending Tier 5

(0.0089%)

since

2024/09/30

28.

Tower Research Capital LLC

(0.0086%)

since

2024/09/30

29.

BNYM Mellon SL Market Completion UC1

(0.0067%)

since

2024/12/31

30.

SSgA U.S. Total Market Index Strategy

(0.0066%)

since

2024/06/30

31.

Northern Trust Wilshire 5000

(0.0014%)

since

2024/12/31

32.

Group One Trading, LP

(0.001%)

since

2024/09/30

33.

Spartan Extended Market Index Pool E

(0.001%)

since

2024/12/31

34.

Advisor Group Holdings, Inc.

(0.0007%)

since

2024/09/30

35.

Barclays PLC

(0.0004%)

since

2024/09/30

37.

Bank of America Corp

(0.0002%)

since

2024/09/30

39.

U.S. Bancorp

(0%)

since

2024/09/30

40.

UBS Group AG

(0%)

since

2024/09/30

* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.

Earnings History

EPS ActualEPS EstimateEPS DifferenceSurprise Percent

Upcoming Earnings Release

Date

—

EPS Estimate

—

Latest Release

Date

2024-09-30

EPS Actual

-0.57

EPS Estimate

-0.64

EPS Difference

0.07

Surprise Percent

10.9375%

Investing Fit Scorecard

(Last Updated 2024-09-30)

Deep Value
Weak Deep Value(2.5)
Defensive
Highly Defensive(7)
Dividend
Weak Dividend Profile(1.5)
Economic Moat
Some Competitive Advantage(5.8)
GARP
Not Attractive for GARP(2.5)
Growth
Weak Growth Prospect(2.5)
Momentum
Moderate Momentum(4)
Net Net
Not Undervalued (Net-Net)(2)
Quality
Low Quality Business(3)
Value
Overpriced(3)

Income Statement

(Last Updated 2024-09-30)

Revenue

$ 0

Cost Of Revenue

$ 0

Gross Profit

$ 0

Operating Expenses

$ 0

Operating Income

$ 0

Interest Expense

$ 0

Pretax Income

$ 0

Net Income

$ 0

Income Tax Expense

$ 0

EBITDA

$ 0

Total Other Income Expense Net

$ 0

Earnings Per Share

0

Dividends Per Share

0

Shares Outstanding

0

Operating Margin

0%

Trend

Balance Sheet

(Last Updated 2024-09-30)

Cash

$ 0

Short Term Investments

$ 0

Receivables

$ 0

Inventories

$ 0

Total Current Assets

$ 0

Property Plant Equipment

$ 0

Total Assets

$ 0

Payables

$ 0

Short Term Debt

$ 0

Long Term Debt

$ 0

Total Liabilities

$ 0

Equity

$ 0

Trend

Cash Flow

(Last Updated 2024-09-30)

Net Income

$ 0

Depreciation

$ 0

Change In Working Capital

$ 0

Cash From Operations

$ 0

Capital Expenditures

$ 0

Cash From Investing

$ 0

Cash From Financing

$ 0

Net Change In Cash

$ 0

Trend

Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.

T2 Biosystems Inc (TTOO) Stock Details & Analysis - Finnton | Finnton